Hypertension and obesity and the risk of kidney cancer in 2 large cohorts of US men and women

Hypertension

Volumn 63, Issue 5, 2014, Pages 934-941

  Sanfilippo, Kristen M ^a,b   McTigue, Kathleen M ^c   Fidler, Christian J ^d   Neaton, James D ^e   Chang, Yuefang ^c   Fried, Linda F ^c,f   Liu, Simin ^g   Kuller, Lewis H ^c  

^a WASHINGTON UNIVERSITY   (United States)

^b Research Service VA Saint Louis Healthcare System   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d ABINGTON MEMORIAL HOSPITAL   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g BROWN UNIVERSITY   (United States)

Author keywords

Blood pressure; Body weight; Epidemiology; Kidney neoplasms; Obesity

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; CANCER MORTALITY; CANCER RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DRUG USE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY CANCER; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OBESITY; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; BODY WEIGHT; EPIDEMIOLOGY; KIDNEY NEOPLASMS; OBESITY;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; COHORT STUDIES; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; KIDNEY NEOPLASMS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBESITY; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 84902288715     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.02953     Document Type: Article

References (35)

1. Chow WH, Devesa SS Contemporary epidemiology of renal cell cancer. Cancer J. 2008; 14: 288-301.
2. Setiawan VW, Stram DO, Nomura A.M., Kolonel LN, Henderson BE Risk factors for renal cell cancer: the multiethnic cohort. Am J Epidemiol. 2007; 166: 932-940. (Pubitemid 47511687)
3. National Cancer Institute. SEER Stat Fact Sheets: Kidney and Renal Pelvis. 2013. Bethseda, MD: National Cancer Institute. http://seer.cancer.gov/ statfacts/html/kidrp.html. Accessed March 4, 2014.
4. Moore LE, Wilson RT, Campleman SL Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk: a review. Cancer Invest. 2005; 23: 240-255. (Pubitemid 40770742)
5. Bergström A., Hsieh CC, Lindblad P, Lu C.M., Cook NR, Wolk A. Obesity and renal cell cancer-a quantitative review. Br J Cancer. 2001; 85: 984-990. (Pubitemid 33016001)
6. Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P. Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer. 2005; 114: 101-108. (Pubitemid 40194314)
7. Schouten LJ, van Dijk BA, Oosterwijk E, Hulsbergen-van de Kaa CA, Kiemeney LA, Goldbohm RA, Schalken JA, van den Brandt PA. Hypertension, antihypertensives and mutations in the Von Hippel-Lindau gene in renal cell carcinoma: results from the Netherlands Cohort Study. J Hypertens. 2005; 23: 1997-2004. (Pubitemid 41830394)
8. Cote ML, Colt JS, Schwartz K.L., Wacholder S., Ruterbusch JJ, Davis F, Purdue M, Graubard B.I., Chow WH. Cigarette smoking and renal cell carcinoma risk among black and white Americans: effect modification by hypertension and obesity. Cancer Epidemiol Biomarkers Prev. 2012; 21: 770-779.
9. Vatten LJ, Trichopoulos D, Holmen J., Nilsen TI Blood pressure and renal cancer risk: the HUNT Study in Norway. Br J Cancer. 2007; 97: 112-114. (Pubitemid 47012085)
10. Weikert S, Boeing H, Pischon T., et al Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition. Am J Epidemiol. 2008; 167: 438-446. (Pubitemid 351264143)
11. Fryzek JP, Poulsen AH, Johnsen S.P., McLaughlin JK, Sørensen HT, Friis S. A cohort study of antihypertensive treatments and risk of renal cell cancer. Br J Cancer. 2005; 92: 1302-1306. (Pubitemid 40604409)
12. Fraser GE, Phillips RL, Beeson WL Hypertension, antihypertensive medication and risk of renal carcinoma in California Seventh-Day Adventists. Int J Epidemiol. 1990; 19: 832-838.
13. Nicodemus KK, Sweeney C, Folsom AR Evaluation of dietary, medical and lifestyle risk factors for incident kidney cancer in postmenopausal women. Int J Cancer. 2004; 108: 115-121. (Pubitemid 37444453)
14. Coughlin SS, Neaton JD, Randall B, Sengupta A. Predictors of mortality from kidney cancer in 332,547 men screened for the Multiple Risk Factor Intervention Trial. Cancer. 1997; 79: 2171-2177. (Pubitemid 27227382)
15. Bjørge T., Tretli S, Engeland A. Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol. 2004; 160: 1168-1176. (Pubitemid 39628057)
16. McGuire BB, Fitzpatrick JM BMI and the risk of renal cell carcinoma. Curr Opin Urol. 2011; 21: 356-361.
17. Luo J, Margolis KL, Adami H.O., Lopez AM, Lessin L, Ye W; Women's Health Initiative Investigators. Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the Women's Health Initiative (United States). Am J Epidemiol. 2007; 166: 752-759. (Pubitemid 47428896)
18. Eberly LE, Stamler J, Kuller L.H., Neaton JD Multiple Risk Factor Intervention Trial (MRFIT). In: D'Agostino RB, Sullivan L, Massaro J, eds. Wiley Encyclopedia of Clinical Trials. Hoboken, NJ: John Wiley & Sons, Inc; 2008: 1-9.
19. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials. 1998; 19: 61-109.
20. Curb JD, McTiernan A, Heckbert S.R., Kooperberg C., Stanford J, Nevitt M, Johnson K.C., Proulx-Burns L, Pastore L, Criqui M, Daugherty S; WHI Morbidity and Mortality Committee. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol. 2003; 13(SUPPL. 9):S122-S128. (Pubitemid 37324181)
21. Renehan AG, Roberts DL, Dive C. Obesity and cancer: pathophysiologi-cal and biological mechanisms. Arch Physiol Biochem. 2008; 114: 71-83. (Pubitemid 351998746)
22. Hora M, Hes O, Reischig T., Urge T, Klecka J, Ferda J., Michal M, Eret V. Tumours in end-stage kidney. Transplant Proc. 2008; 40: 3354-3358.
23. Lipworth L, Tarone RE, McLaughlin JK The epidemiology of renal cell carcinoma. J Urol. 2006; 176(6 Pt 1): 2353-2358. (Pubitemid 44665976)
24. Klag MJ, Whelton PK, Randall B.L., Neaton JD, Brancati FL, Ford CE, Shulman N.B., Stamler J. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996; 334: 13-18. (Pubitemid 26012498)
25. Wentworth DN, Neaton JD, Rasmussen WL An evaluation of the Social Security Administration master beneficiary record file and the National Death Index in the ascertainment of vital status. Am J Public Health. 1983; 73: 1270-1274. (Pubitemid 13009070)
26. Leiba A, Kark JD, Afek A, Derazne E., Keinan-Boker L, Shamiss A, Kreiss Y. Hypertension in adolescence is not an independent risk factor for renal cancer: a cohort study of 918,965 males. J Am Soc Hypertens. 2013; 7: 283-288.
27. Khandekar MJ, Cohen P, Spiegelman BM Molecular mechanisms of cancer development in obesity. Nat Rev Cancer. 2011; 11: 886-895.
28. Kaelin WG Jr. The von Hippel-Lindau gene, kidney cancer, and oxygen sensing. J Am Soc Nephrol. 2003; 14: 2703-2711. (Pubitemid 37305632)
29. Gago-Dominguez M., Castelao JE, Yuan J.M., Ross RK, Yu MC Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes Control. 2002; 13: 287-293. (Pubitemid 34438239)
30. Gago-Dominguez M., Castelao JE Lipid peroxidation and renal cell carcinoma: further supportive evidence and new mechanistic insights. Free Radic Biol Med. 2006; 40: 721-733. (Pubitemid 43170824)
31. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004; 4: 579-591. (Pubitemid 39025053)
32. Spyridopoulos TN, Petridou ET, Skalkidou A, Dessypris N., Chrousos GP, Mantzoros CS; Obesity and Cancer Oncology Group. Low adiponectin levels are associated with renal cell carcinoma: a case-control study. Int J Cancer. 2007; 120: 1573-1578. (Pubitemid 46355396)
33. Nickerson ML, Jaeger E, Shi Y., et al Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Clin Cancer Res. 2008; 14: 4726-4734.
34. Shapiro JA, Williams MA, Weiss N.S., Stergachis A., LaCroix AZ, Barlow WE Hypertension, antihypertensive medication use, and risk of renal cell carcinoma. Am J Epidemiol. 1999; 149: 521-530. (Pubitemid 29130019)
35. Friis S, Sørensen HT, Mellemkjaer L, McLaughlin JK, Nielsen GL, Blot WJ, Olsen JH. Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark. Cancer. 2001; 92: 2462-2470. (Pubitemid 33029093)